- Presentations
- 3
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Zilucoplan is a complement Inhibitor. MedsAcross lists 3 presentations of it from 1 manufacturers, with brand names, strengths, packs and regulatory status for each. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Complement Inhibitor, Complement Inhibitors
- ATC classification
- L04AJ06 Zilucoplan · Immunosuppressive drug, subgroup L04AJ
- US FDA first approval
- 17 October 2023
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Subcutaneous
- Dosage forms
- Injection
- Identifiers
- UNII YG391PK0CCCAS 1841136-73-9DrugBank DB15636Q107340140
All presentations
3 presentations of Zilucoplan, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Zilbrysq 16.64 mg/0.416 mL injectionSubcutaneous | UCB | US FDA | Available on request |
| Zilbrysq 22.96 mg/0.574 mL injectionSubcutaneous | UCB | US FDA | Available on request |
| Zilbrysq 32.4 mg/0.81 mL injectionSubcutaneous | UCB | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions
Conditions linked to Zilucoplan in public data. This is not a list of approved uses, see the clinical information.
Questions and answers
Is Zilucoplan available for export from India?
Yes, on request. MedsAcross lists 3 presentations of Zilucoplan and sources them for licensed hospitals, importers and physicians against valid import documents.
What brand names does Zilucoplan have?
The catalogue lists 1 brand names for Zilucoplan, including Zilbrysq.
Is Zilucoplan approved by the US FDA?
Yes. The US FDA first approved Zilucoplan on 17 October 2023, according to Drugs@FDA.
Is Zilucoplan authorised in the European Union?
Yes. Zilucoplan has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Zilucoplan need cold chain shipping?
No listed presentation of Zilucoplan is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Zilucoplan in?
Zilucoplan is classified under ATC code L04AJ06 (Zilucoplan).
References
- Zilbrysq: European public assessment report (EPAR). European Medicines Agency. Retrieved 9 September 2026
Request Zilucoplan for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.